| 1 (100) | Hoffmann-La Roche Ltd, United States | USA |  |
| 2 (103) | Bristol-Myers Squibb Company, United States | USA | |
| 3 (107) | Genentech Inc | USA | |
| 3 (107) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 3 (107) | Novartis Institutes for Biomedical Research, United States | USA | |
| 6 (121) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 7 (125) | AbbVie Inc, United States | USA | |
| 8 (132) | Regeneron Pharmaceuticals Inc | USA | |
| 9 (153) | AstraZeneca, United Kingdom | GBR | |
| 10 (155) | AstraZeneca, United States | USA | |
| 11 (168) | Merck & Co Inc, United States | USA | |
| 12 (189) | Pfizer Inc, United States | USA | |
| 13 (191) | Eli Lilly and Company, United States | USA | |
| 14 (199) | Janssen Biotech Inc | USA | |
| 15 (209) | Bayer AG, Germany | DEU | |
| 15 (209) | Merck KGaA, Germany | DEU | |
| 17 (218) | Philips Research, Eindhoven | NLD | |
| 18 (226) | Foundation Medicine Inc | USA | |
| 19 (237) | Gilead Sciences Inc, United States | USA | |
| 20 (295) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 21 (343) | Celgene Corp | USA | |
| 22 (354) | Amgen, USA | USA | |
| 23 (382) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 24 (409) | Novartis, Switzerland | CHE | |
| 25 (416) | GlaxoSmithKline, United States | USA | |
| 26 (419) | Translational Research Institute | AUS | |
| 27 (458) | Novartis Pharmaceuticals, United States | USA | |
| 28 (479) | Boehringer Ingelheim GmbH Germany | DEU | |
| 29 (485) | Janssen Research & Development, LLC | BEL | |
| 30 (506) | Sanofi, United States | USA | |
| 31 (515) | Siemens AG, Germany | DEU | |
| 32 (551) | Bayer Corp, USA | USA | |
| 33 (553) | Novo Nordisk A/S | DNK | |
| 34 (783) | RTI Health Solutions | USA | |
|
